Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT00686946
Registration number
NCT00686946
Ethics application status
Date submitted
28/05/2008
Date registered
30/05/2008
Date last updated
28/11/2023
Titles & IDs
Public title
The National Register of Antipsychotic Medication in Pregnancy (NRAMP)
Query!
Scientific title
The National Register of Antipsychotic Medication in Pregnancy (NRAMP)
Query!
Secondary ID [1]
0
0
114/04
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
NRAMP
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Pregnancy
0
0
Query!
Mental Disorders
0
0
Query!
Condition category
Condition code
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
NRAMP - Participants take their antipsychotic medication as prescribed by their clinical treating teams.
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Participant interviews
Query!
Assessment method [1]
0
0
Interviews to gather demographic, social, medical, psychiatric, medication and obstetric history
Query!
Timepoint [1]
0
0
Antenatal - once per trimester; Postnatal - quarterly for 12 months
Query!
Secondary outcome [1]
0
0
Psychopathology measures for the mother
Query!
Assessment method [1]
0
0
PANSS (Positive and Negative Syndrome Scale) Questionnaire EPDS (Edinburgh Postnatal Depression Scale)Questionnaire
Query!
Timepoint [1]
0
0
Antenatal and up to 12 months postnatally
Query!
Secondary outcome [2]
0
0
Developmental Milestone measures for the baby
Query!
Assessment method [2]
0
0
ASQ-3 (Ages and Stages Questionnaire, Third Edition)
Query!
Timepoint [2]
0
0
Birth to 12 months of age
Query!
Eligibility
Key inclusion criteria
- Women who take antipsychotic medication during pregnancy
- Women who are pregnant or have had a baby in the last 12 months
- Women who are living in Australia
- Women who are able to provide informed consent
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
50
Years
Query!
Query!
Sex
Females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- Women who do not take antipsychotic medication during pregnancy
- Women who are not pregnant, or have not had a baby in the last 12 months
- Women who are unable to provide informed consent
Query!
Study design
Purpose
Query!
Duration
Query!
Selection
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/01/2005
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
1/12/2025
Query!
Actual
Query!
Sample size
Target
500
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
0
0
Monash Alfred Pyschiatry Research Centre, Alfred Hospital - Melbourne
Query!
Recruitment postcode(s) [1]
0
0
3004 - Melbourne
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
The Alfred
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Commercial sector/Industry
Query!
Name [1]
0
0
Janssen-Cilag Ltd.
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Other collaborator category [2]
0
0
Commercial sector/Industry
Query!
Name [2]
0
0
AstraZeneca
Query!
Address [2]
0
0
Query!
Country [2]
0
0
Query!
Other collaborator category [3]
0
0
Commercial sector/Industry
Query!
Name [3]
0
0
Hospira, now a wholly owned subsidiary of Pfizer
Query!
Address [3]
0
0
Query!
Country [3]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The National Register of Antipsychotic Medication in Pregnancy (NRAMP)is an observational,
nationwide study involving women of child-bearing age who take antipsychotic medication
during pregnancy. It follows the pathway of mother and baby during pregnancy and for the
first 12 months of the baby's life, in order to develop evidence-based guidelines for the
best use and effect of antipsychotic medication during pregnancy, thereby informing clinical
treating teams with regard to the management of their patients in this vulnerable population
group.
The investigators hypothesize that the provision of such evidence-based guidelines will
improve the management and outcomes for mother and baby during pregnancy, birth and the
postnatal phase, providing a positive impact on maternal and child health and wellbeing for
present and future generations.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT00686946
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Prof Jayashri Kulkarni, MBBS,FRANZCP
Query!
Address
0
0
Monash Alfred Psychiatry Research Centre (MAPrc)
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Prof Jayashri Kulkarni, MBBS,FRANZCP
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
61-3-9076-6564
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT00686946
Download to PDF